'I have a feel­ing': Trump-en­dorsed malar­ia drug fails to pass muster in small Chi­nese coro­n­avirus study

De­spite the FDA’s re­luc­tance to en­dorse with­out de­fin­i­tive clin­i­cal tri­al da­ta the decades-old an­ti-malar­i­al drugs chloro­quine and de­riv­a­tive hy­drox­y­chloro­quine as treat­ments to com­bat the coro­n­avirus scourge, in re­cent days Pres­i­dent Trump has trum­pet­ed his faith — on the ba­sis of a ‘feel­ing’ — that the drugs would work. Now, a key an­a­lyst has found tri­al da­ta that con­tra­dict the pos­i­tive con­clu­sions of a small Chi­nese study that re­searchers ini­tial­ly based on their en­thu­si­asm on.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER